Andreab Thomas News Today

James Investment Research Inc. cut its stake in shares of Medifast, Inc. (NYSE:MED – Get Rating) by 75.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 662 shares of the specialty retailer’s stock after selling 2,062 shares during the quarter. James Investment Research Inc.’s holdings in Medifast were worth $139,000 as of […]

Medifast (NYSE:MED – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $14.500-$16.000 for the period, compared to the Thomson Reuters consensus estimate of $15.960. The company issued revenue guidance of $1.72 billion-$1.79 billion, compared to the consensus revenue estimate of $1.74 billion. A number […]